R.H. Bluestein & Co’s Tandem Diabetes Care TNDM Stock Holding History

R.H. Bluestein & Co’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-3,513	Closed	-$208K	–	365
2022 Q2	$208K	Hold	3,513	–	–	0.01%	334
2022 Q1	$409K	Hold	3,513	–	–	0.02%	230
2021 Q4	$529K	Hold	3,513	–	–	0.02%	207
2021 Q3	$419K	Hold	3,513	–	–	0.02%	247
2021 Q2	$342K	Hold	3,513	–	–	0.01%	294
2021 Q1	$310K	Hold	3,513	–	–	0.01%	301
2020 Q4	$336K	Sell	3,513 -50	-1%	-$5.15K	0.01%	255
2020 Q3	$404K	Hold	3,563	–	–	0.02%	195
2020 Q2	$352K	Hold	3,563	–	–	0.02%	202
2020 Q1	$229K	Sell	3,563 -2,000	-36%	-$140K	0.02%	228
2019 Q4	$332K	Buy	+5,563	New	+$343K	0.02%	255
2016 Q4	–	Sell	-1,063	Closed	-$81K	–	322
2016 Q3	$81K	Hold	1,063	–	–	0.01%	291
2016 Q2	$80K	Sell	1,063 -450	-30%	-$36.2K	0.01%	286
2016 Q1	$132K	Hold	1,513	–	–	0.01%	280
2015 Q4	$179K	Buy	1,513 +13	+0.9%	+$1.29K	0.01%	277
2015 Q3	$132K	Hold	1,500	–	–	0.01%	296
2015 Q2	$163K	Hold	1,500	–	–	0.01%	319
2015 Q1	$189K	Buy	+1,500	New	+$195K	0.01%	322

Other funds holding TNDM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

R.H. Bluestein & Co's TNDM Position: Q3 2022 in Review

R.H. Bluestein & Co sold out of Tandem Diabetes Care (TNDM) in Q3 2022, closing a stake of 3,513 shares — an estimated $208K sold.

R.H. Bluestein & Co first reported a position in TNDM in Q1 2015 and held it in 18 quarters. The position peaked at $529K in Q4 2021. 299 funds tracked by Wall St. Rank hold TNDM as of Q3 2022.

R.H. Bluestein & Co reported no remaining Tandem Diabetes Care position as of Q3 2022 after selling out during the quarter.
R.H. Bluestein & Co sold 3,513 Tandem Diabetes Care shares in Q3 2022, an estimated $208K.
R.H. Bluestein & Co first reported a position in Tandem Diabetes Care in Q1 2015 and held it in 18 quarters.
R.H. Bluestein & Co's Tandem Diabetes Care position peaked at $529K in Q4 2021.
299 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q3 2022.

Based on R.H. Bluestein & Co's 13F filing for Q3 2022, filed 14 Nov 2022.